First report of a comparative patient-oriented perspective on the use of non-vitamin-K oral anticoagulants or vitamin-K antagonists in atrial fibrillation: patients’ experiences, side-effects and practical problems leading to non-adherence

BACKGROUND: Non-vitamin‑K oral anticoagulants (NOACs) are recommended as the first-choice therapy for stroke prevention in patients with non-valvular atrial fibrillation (AF). However, the lack of monitoring may impact patients’ adherence, and non-adherence to medication is a potential hazard to saf...

Descripción completa

Detalles Bibliográficos
Autores principales: Bennaghmouch, N., de Veer, A. J. W. M., Zivelonghi, C., van Dijk, L., ten Berg, J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890911/
https://www.ncbi.nlm.nih.gov/pubmed/31745815
http://dx.doi.org/10.1007/s12471-019-01331-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890911/
https://www.ncbi.nlm.nih.gov/pubmed/31745815
http://dx.doi.org/10.1007/s12471-019-01331-x

Ejemplares similares